2025 third_quarter Filing
Q3Lobbying Activities
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY26; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY26; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26; Tribal Opioid Response Grant funding for FY26; NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone; H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025; H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025; H.R. 5252, Having Overdoes Protection Equipment Act.
Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act; Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY26; Opioid crisis legislation, naloxone access and awareness; State opioid response (SOR) Grant funding FY26; Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY26; Tribal Opioid Response Grant funding for FY26; NDAA for Fiscal Year 2025 and Fiscal Year 2026 - provisions related to biological and chemical defense and access to naloxone; H.R. 1968, the Full-Year Continuing Appropriations and Extensions Act, 2025; H.R. 2483, SUPPORT for Patients and Communities Reauthorization Act of 2025; H.R. 5252, Having Overdoes Protection Equipment Act.